Fried Robert N
SEC insider (Form 3/4/5 filer). CIK 0001417952. Chief Executive Officer at Niagen Bioscience, Inc. (NAGE). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in LOS ANGELES, CA.
Companies Fried Robert N has filed insider reports for
- Niagen Bioscience, Inc. (NAGE): Director, Officer, Chief Executive Officer
Fried Robert N
CIK: 0001417952
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Niagen Bioscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 30, 2026NAGE
Niagen Bioscience, Inc.
AwardDirect1.1K shares at avg. $2.71$3K - Apr 24, 2026NAGE
Niagen Bioscience, Inc.
ExerciseDirect20K shares at avg. $2.61$52K - Feb 19, 2026NAGE
Niagen Bioscience, Inc.
AwardDirectEmployee Stock Options (right to buy)
503.9K shares- - Apr 9, 2025NAGE
Niagen Bioscience, Inc.
ExerciseDirect66.7K shares at avg. $3.30$220K - Feb 25, 2025CDXC
ChromaDex Corp.
AwardDirectPerformance Stock Unit
1.5M shares- - Feb 12, 2025CDXC
ChromaDex Corp.
AwardDirectEmployee Stock Options (right to buy)
492.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | NAGE Niagen Bioscience, Inc. | Award | 1,106 | $2.71 | $2,997 | Direct |
| Apr 24, 2026 | NAGE Niagen Bioscience, Inc. | Exercise | 20,000 | $2.61 | $52,200 | Direct |
| Feb 19, 2026 | NAGE Niagen Bioscience, Inc. | Award Employee Stock Options (right to buy) | 503,937 | - | - | Direct |
| Apr 9, 2025 | NAGE Niagen Bioscience, Inc. | Exercise | 66,667 | $3.30 | $220,001 | Direct |
| Feb 25, 2025 |  CDXC ChromaDex Corp. | Award Performance Stock Unit | 1,518,600 | - | - | Direct |
| Feb 12, 2025 | CDXC ChromaDex Corp. | Award Employee Stock Options (right to buy) | 492,278 | - | - | Direct |
1-6 of 6 transactions